Business

2d college gets meningitis vaccine

GENEVA — The Swiss drug maker Novartis said a second US university is using its new vaccine against meningitis B. The vaccine, Bexsero, is being used at the University of California Santa Barbara until March 7 to help protect 20,000 students and staff after an outbreak.

The vaccine shot for the B strain of the meningitis bacteria is approved for use in Europe, Australia, and Canada, but not yet for general use in the United States.

Advertisement

But the Food and Drug Administration has approved the use of Bexsero twice in response to outbreaks at college campuses. It is the first vaccine against the B strain of meningitis.

Princeton University said that almost 5,300 people got the vaccine last year in an effort to halt an outbreak there.

Associated Press

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com